Payers Are Using AI to Predict Which Denials You Won't Appeal

The question payers are asking isn't always "Is this claim payable?" Increasingly, it's "Will this provider bother to fight it?" That shift changes everything about how you should be managing denials.

11%
Denial rate in 2023, up from 8% in 2021 (AMA)
$57
Average cost per denial worked in 2023, up 30% in one year
$20B
Spent annually by providers trying to overturn denials

I've spent enough time in revenue cycle to know the playbook. Claim comes in denied, you triage it, you work the ones worth working, and you let the marginal ones go. Every director knows the math: if it costs $57 in labor to appeal a $40 claim, you eat the loss.

Payers know that math too. That's the problem.

From Rules-Based to Behavior-Based Denials

For most of RCM's history, payer denials were fundamentally rules-based. Medical necessity criteria, coding mismatches, authorization gaps — the claim failed a defined policy check. You knew why it was denied, and you knew how to fix it.

That model hasn't disappeared. But a layer has been added on top of it that most revenue cycle teams haven't fully reckoned with.

Modern AI-enabled analytics give payers the ability to look back across years of claims and model provider behavior at a granular level. They know which denial codes you appeal most aggressively, which service lines see low appeal volume, where your internal review thresholds sit, and how long it takes your team to respond. Fed into decision engines, that behavioral data allows payers to assign what are effectively "denial risk scores" — probability estimates not of clinical incorrectness, but of provider response.

The strategic implication

A denial with a low probability of being appealed becomes a low-risk decision, even if it's clinically questionable. A small underpayment that consistently goes unnoticed becomes easy revenue. Multiply across millions of claims and the math works — for the payer.

This isn't a fringe theory. Paul Havey, Chief Commercial Officer at Revecore and a former Change Healthcare executive, put it plainly in MedCity News this week: payers are using AI "to predict provider behavior," not just enforce medical necessity rules. The question being asked isn't always "Is this claim payable?" It's often, "Will this be worth the provider's effort to appeal?"

Why the Revenue Erosion Is Hard to See

What makes behavior-based denial strategy particularly difficult is that it doesn't show up as a spike on your denial dashboard. Denial rates can stay flat — or even dip — while revenue quietly erodes. The losses are distributed across service lines, payers, and claim types in ways that blend into the baseline.

You're not looking at a wall of denials. You're looking at a thousand small decisions that each seem individually defensible: this one wasn't worth the labor cost to appeal, that one fell below the review threshold, this other one was for a service line we don't prioritize.

Over time, those decisions calcify into expected reimbursement. The underpayment becomes the rate. The behavior-triggered denial becomes the norm. And your team never flags it because nothing triggered an alert.

The Questions Your Data Should Be Answering

If payers are modeling your behavior to optimize their denial strategy, you need to do the same thing in reverse — model their behavior to find where the pattern breaks.

The right questions have shifted:

  • Which denial categories have the lowest appeal rates — and are those denials actually valid, or just inconvenient?
  • Where do underpayments consistently land just below your internal review thresholds?
  • Which payers show a pattern of "soft denials" that don't trigger your standard workflows?
  • How often is your team choosing not to appeal because of effort-to-yield ratio rather than merit?
  • What denial reason codes correlate with high payer profitability on low-appeal claims?

MGMA data point

Nearly 60% of providers reported year-over-year increases in claim denials. But the volume number alone tells you nothing about whether those denials are strategically designed to succeed — or just operationally sloppy.

Volume metrics get you reactive. Pattern metrics get you ahead of the strategy. The difference is whether you're analyzing denials as isolated transactions or as a signal about payer behavior across time and service line.

What "Fighting Back With Data" Actually Looks Like

The providers gaining ground here aren't just appealing faster. They're building analytical capacity that mirrors what payers already have.

That means stratifying your denial inventory not just by reason code and dollar amount, but by estimated cost-to-appeal, historical overturn rate, and evidence of pattern-based denial across multiple claims. When you can show a payer a cohort of 400 denials that all share the same coding structure, the same modifier pattern, and a statistically anomalous appeal rate — that's a different conversation than presenting a single appeal.

It also means building visibility into underpayments that don't reach the surface. Systematic underpayment — where contract rates aren't applied correctly, or where bundling decisions consistently tilt toward the payer — often goes unworked because no single instance clears the threshold. In aggregate, it's frequently one of the largest revenue leaks on the books.

When data-backed patterns replace anecdotal frustration in payer contract discussions, the dynamic shifts. Providers who've done this work report that pattern documentation changes the character of renegotiations — you're no longer arguing about one claim, you're arguing about a demonstrated practice.

The Operating Margin Reality

Health system operating margins hit a median of 1.2% in Q4 2025 — the strongest quarter of the year, and still paper thin. There is no margin of error for reimbursement leakage that blends into the baseline and never gets questioned.

The biggest risk in today's payer environment isn't the denial that lands in a work queue. It's the one designed to never get there.

As AI becomes more embedded in payer decision engines, the sophistication of denial strategy will only increase. Revenue integrity teams that are still triaging by timely filing deadlines and dollar thresholds are working a problem that's evolved past them.

The equalizer is the same tool payers are using: data. Not more of it — better pattern recognition on what you already have. The providers who surface the behavior behind the denials will stop being the ones that behavior is designed to exploit.

Reaching RCM decision-makers? Advertise with RevCycleAI →